查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1993108

消化道出血治疗器材市场：依产品类型、技术、适应症、应用和最终用户划分－2026-2032年全球市场预测

Gastrointestinal Bleeding Treatment Devices Market by Product Type, Technology, Indication Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，用于治疗消化道出血的设备市场价值将达到 5.9093 亿美元，到 2026 年将增长到 6.2741 亿美元，到 2032 年将达到 8.5929 亿美元，复合年增长率为 5.49%。

主要市场统计数据
基准年 2025 5.9093亿美元
预计年份：2026年 6.2741亿美元
预测年份 2032 8.5929亿美元
复合年增长率 (%) 5.49%

为了支持知情的策略决策，本简要概述了影响胃肠道出血医疗设备市场趋势的临床、技术和商业性因素。

消化道出血仍然是一项重要的临床挑战，对病患预后、医院工作流程和医疗设备创新产生重大影响。本执行摘要整合了当前影响用于诊断、控制和管理上消化道和下消化道出血的医疗设备市场的趋势，重点介绍了对临床医生、医院采购团队和医疗技术负责人至关重要的技术进步、临床实践的转变以及商业性压力。

临床实务、医疗设备创新和数据驱动的程序改进如何融合，从而重塑整个出血治疗器材市场的治疗路径和商业模式？

治疗消化道出血的器械市场正经历一系列变革，这主要得益于器械设计、手术流程以及数据驱动的临床支援的进步。器械符合人体工学的改进、种类更丰富的耗材以及先进的止血材料的出现，都缩短了手术时间，降低了手术复杂性，从而推动了微创内镜治疗的临床应用范围不断扩大。同时，对于内视镜治疗无效的病例，放射介入和混合治疗方案也日益受到重视，这体现了多学科诊疗模式的概念，即透过协作决策优化患者预后。

评估 2025 年价格调整对供应链的影响，以及製造商和供应商如何调整采购、库存管理和合约以维持临床连续性。

2025年关税的实施和贸易政策调整给整个医疗设备供应链带来了巨大压力，尤其对用于治疗消化道出血的组件和成品造成了严重影响。依赖跨境采购聚合物组件、特殊黏合剂和高精度电子子系统的製造商面临更高的接收成本，被迫重新评估其地理筹资策略和库存管理实践。为此，一些公司加快了近岸外包的步伐，并实现了供应商多元化，以确保供应的连续性并降低进一步关税措施的风险。

全面的细分洞察揭示了产品类型、技术方法、临床应用、最终用户和适应症亚型如何决定采用趋势。

要了解消化道出血治疗器材领域的临床应用模式和产品开发重点，需要从细分市场的观点，捕捉哪怕是最细微的差别。根据产品类型，内视镜止血夹、止血剂、注射疗法和热疗器械各自具有不同的临床适应症和操作特性。特别是止血剂，其剂型多样，例如粉末、片状和喷雾剂，由于其释放速度和表面黏附性存在差异，因此需要仔细选择。注射疗法包括酒精硬化剂、肾上腺素和聚多卡醇，每种药物的选择都取决于病灶的特征和操作者的偏好。同时，氩等离子体凝固、双极探头和加热探头等热疗器械仍是靶向凝血的主要工具。

区域支付方结构、医疗服务提供者能力和人口趋势如何影响全球医疗保健市场的需求模式差异和技术采用？

区域趋势对全球消化道出血治疗器械的进入模式、报销途径和技术应用有显着影响。在美洲，一体化的医院系统和高度整合的供应商体系创造了一个环境，​​在这种环境下，资本投资、手术量和报销奖励都会在采购决策中得到权衡，而私人保险公司也经常影响器械的选择和价格谈判。组织完善的临床网路以及微创技术在展现出明确的临床和经济效益后能够相对快速推广的环境，为持续的创新循环提供了支持。

竞争对手的策略重点在于整合产品系列、临床证据计划和服务模式，以加速产品推广并加强与医疗保健提供者的长期关係。

製造商之间的竞争地位日益取决于整合的产品组合、实证实践能力和服务导向经营模式。领先的医疗设备製造商正在投资开发模组化系统，将止血剂和专用给药装置结合，并建立培训和支援系统，以缩短学习曲线并加快医院部署。医疗设备创新者与临床研究网络之间的策略合作正在扩大真实世界数据 (REW) 的生成，从而能够更清晰地展示流程效率和临床结果，这些成果能够引起临床医生和支付方的共鸣。

为製造商和供应商提供切实可行的策略行动，将临床创新转化为成功的部署，同时加强供应链和商业性韧性。

产业领导者应优先考虑一系列切实可行的策略，以提升临床效用、增强营运韧性并实现商业性差异化。首先，应投资收集临床证据，将器械使用与可衡量的结果连结起来，例如降低再出血率、缩短手术时间和降低整体治疗成本。这些数据将有助于与支付方进行谈判，并增强医院的采购决策。其次，在设计医疗设备及相关係统时，应充分考虑供应链冗余，以减少对单一供应商的依赖，并确保有备选方案能够快速应对政策和物流方面的突发状况。

采用稳健的多源方法，结合对临床医生的访谈、对监管和技术文件的审查以及真实世界数据 (REW) 的整合，以检验趋势和见解。

本研究整合了同行评审的临床文献、监管文件、产品技术规范以及对临床医生、医院采购经理和行业高管的访谈，从而对当前消化道出血治疗器械的现状进行了多角度的分析。研究透过对熟悉内视镜、放射和外科出血治疗的临床医生进行结构化访谈，收集了关键的定性见解；此外，还与供应链和采购专家进行了匿名讨论，以了解采购限制和合约偏好。

整合关键见解，将临床创新、供应链韧性和实证应用与长期的商业性和病患影响连结起来。

总之，消化道出血治疗器材领域正处于临床需求与技术机会的交会点。止血剂、精密内视镜配件以及辅助放射学手段的进步，正在扩大临床医师可用的治疗工具。同时，供应链压力和支付方期望的改变，正在重塑产品的采购和使用方式。策略差异化将越来越依赖在特定适应症和医疗环境中证明临床疗效的能力、提供稳健的供应和服务模式的能力，以及提供可扩展的培训以将新技术融入日常实践的能力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：消化道出血治疗器材市场：依产品类型划分

  • 内视镜夹
  • 止血剂
    • 粉末
    • 座位
    • 喷
  • 注射疗法
    • 酒精硬化剂
    • 肾上腺素
    • 聚多卡醇
  • 热疗设备
    • 氩气等离子凝固
    • 双极探针
    • 加热探针

第九章：消化道出血治疗设备市场：依技术划分

  • 内视镜
    • 软式内视镜
    • 硬式内视镜
  • 放射学
    • 血管造影术导引下栓塞术
    • 肠繫膜支架
  • 外科
    • 腹腔镜手术
    • 开放性手术

第十章：以适应症分類的消化道出血治疗器械市场

  • 下消化道
    • 结肠出血
    • 直肠出血
  • 上消化道
    • 十二指肠出血
    • 食道出血
    • 胃出血

第十一章：消化道出血治疗设备市场：依应用领域划分

  • 血管畸形
  • 迪拉福伊病变
  • 马洛里-韦斯撕裂伤
  • 消化性溃疡
  • 静脉曲张出血

第十二章：消化道出血治疗设备市场：依最终用户划分

  • 门诊手术中心
  • 胃肠病诊所
  • 医院（住院病人）
  • 医院门诊部

第十三章：消化道出血治疗器械市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：消化道出血治疗器材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：消化道出血治疗器械市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国消化道出血治疗器材市场

第十七章：中国消化道出血治疗器材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cantel Medical Corporation
  • ConMed Corporation
  • Cook Medical LLC
  • EndoClot Plus, Inc.
  • Erbe Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medline Industries, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Smiths Group plc
  • Steris plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-1A1A064C0286

The Gastrointestinal Bleeding Treatment Devices Market was valued at USD 590.93 million in 2025 and is projected to grow to USD 627.41 million in 2026, with a CAGR of 5.49%, reaching USD 859.29 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 590.93 million
Estimated Year [2026] USD 627.41 million
Forecast Year [2032] USD 859.29 million
CAGR (%) 5.49%

A concise orienting overview that frames clinical, technological, and commercial drivers shaping the gastrointestinal bleeding device landscape for informed strategic decision making

Gastrointestinal bleeding remains a critical clinical challenge with significant implications for patient outcomes, hospital workflows, and device innovation. This executive summary synthesizes current dynamics shaping the device landscape used to diagnose, control, and manage bleeding across upper and lower gastrointestinal tracts, emphasizing technological evolution, clinical practice shifts, and commercial pressures that matter to clinicians, hospital procurement teams, and medtech strategists.

The narrative that follows contextualizes the device ecosystem-spanning endoscopic clips, hemostatic agents, injection therapies, and thermal modalities-within the broader movement toward minimally invasive interventions and value-based care. It highlights how procedural preferences, regulatory developments, and payer behavior are influencing product adoption. Throughout, the focus remains practical: identify where clinical need intersects with technological capability and where operational constraints create opportunities for differentiated solutions.

By framing these trends against supply chain realities and emerging policy changes, the introduction sets the stage for granular segmentation, regional variances, corporate competitive positioning, and pragmatic recommendations. Readers will find an integrated view that connects clinical practice to commercial implications and provides a foundation for evidence-informed decision-making.

How converging clinical practices, device innovation, and data-driven procedural enhancements are reshaping treatment pathways and commercial models across the bleeding device landscape

The landscape for gastrointestinal bleeding treatment devices is undergoing a series of transformative shifts driven by advances in device design, procedural technique, and data-enabled clinical support. Minimally invasive endoscopic therapies continue to expand their clinical remit, supported by improvements in device ergonomics, single-use accessory options, and refined hemostatic materials that reduce procedural time and complexity. Concurrently, radiologic and hybrid approaches have gained traction for cases refractory to endoscopic care, reflecting multidisciplinary care pathways that optimize patient outcomes through collaborative decision-making.

Technological convergence is another critical vector of change, with imaging enhancements, artificial intelligence-assisted lesion detection, and integrated hemostasis delivery systems improving the precision and predictability of interventions. These developments are altering training paradigms and shifting competency expectations for endoscopists and interventional radiologists alike. At the same time, commercial dynamics-such as vendor consolidation, strategic partnerships between device manufacturers and hospital systems, and an emphasis on lifecycle cost reduction-are reshaping procurement models, encouraging bundled offerings and service-oriented contracts.

Ultimately, these transformative shifts are accelerating adoption of novel hemostatic agents and procedural adjuncts while tightening the requirements for clinical evidence and real-world outcome data that demonstrate value. The cumulative effect is a more complex but opportunity-rich marketplace where differentiated clinical performance and integrated service models will define winners.

Assessment of 2025 tariff-driven supply chain responses and how manufacturers and providers adapted sourcing, inventory, and contracting to preserve clinical continuity

The introduction of tariffs and trade policy adjustments in 2025 introduced measurable pressures across medical device supply chains, with particular relevance to components and finished devices used in gastrointestinal bleeding management. Manufacturers that rely on cross-border sourcing of polymeric components, specialized adhesives, and high-precision electrical subsystems experienced increases in landed costs that prompted reassessments of geographic sourcing strategies and inventory practices. In response, several companies accelerated nearshoring initiatives and diversified supplier bases to protect continuity of supply and mitigate exposure to additional tariff actions.

Clinical providers encountered the downstream effects of these supply chain adjustments through tighter lead times and, in some cases, temporary product reallocations across facilities. Procurement teams intensified efforts to secure contract terms that included price protection clauses and prioritized suppliers with redundant manufacturing footprints. Regulatory compliance and quality management systems emerged as decisive differentiators, as buyers favored vendors with robust documentation and validated alternative sourcing approaches that minimize disruption risk.

While tariffs contributed to short-term cost pressures, the resultant strategic responses catalyzed enduring operational changes. Manufacturers made targeted capital investments to increase domestic manufacturing capacity and implemented design modifications to reduce reliance on tariff-impacted inputs. These measures, combined with more collaborative contracting and enhanced transparency across the supply chain, are contributing to a more resilient ecosystem even as policymakers continue to assess trade frameworks.

Comprehensive segmentation insights revealing how product types, technological approaches, clinical applications, end users, and indication subtypes determine adoption dynamics

A nuanced segmentation lens is essential to understand clinical adoption patterns and product development priorities across the gastrointestinal bleeding device space. Based on product type, endoscopic clips, hemostatic agents, injection therapies, and thermal devices each carry distinct clinical indications and operational profiles; hemostatic agents warrant closer attention because they span powder, sheets, and spray formats that offer varying deployment speed and surface conformity. Injection therapy comprises alcohol sclerosant, epinephrine, and polidocanol, with each agent selected based on lesion characteristics and operator preference, while thermal devices such as argon plasma coagulation, bipolar probes, and heater probes remain core tools for targeted coagulation.

From a technology standpoint, the market intersects endoscopic, radiologic, and surgical modalities. Endoscopic approaches are further differentiated into flexible and rigid endoscopy, reflecting procedural settings and access requirements; radiologic interventions include angiographic embolization and mesenteric stenting to manage bleeding inaccessible or refractory to endoscopy; surgical approaches continue to encompass laparoscopic and open surgery when definitive anatomic control is required. Application-based segmentation-encompassing angiodysplasia, Dieulafoy lesions, Mallory-Weiss tears, peptic ulcers, and variceal bleeding-illustrates how pathology-specific device choices and clinical pathways drive clinician preferences.

End-user segmentation includes ambulatory surgical centers, gastroenterology clinics, hospital inpatient services, and hospital outpatient departments, each with different throughput, capital intensity, and procurement cycles that influence purchasing decisions. Indication type divides the domain into lower and upper GI bleeding; lower GI further differentiates into colonic and rectal bleeding, while upper GI captures duodenal, esophageal, and gastric bleeding subtypes. Together, these overlapping segmentation dimensions reveal where innovation can yield differentiated clinical value, how reimbursement and setting-of-care considerations alter uptake, and where targeted clinical evidence will most effectively support adoption.

How regional payer structures, provider capabilities, and demographic trends shape differentiated demand patterns and technology adoption across global healthcare markets

Regional dynamics materially shape access models, reimbursement pathways, and technology adoption for gastrointestinal bleeding treatment devices across the world. In the Americas, integrated hospital systems and a highly consolidated supplier base create an environment where purchasing decisions weigh capital expenditures against procedural throughput and reimbursement incentives, and private payers frequently influence device selection and pricing negotiations. Continuous innovation cycles are supported by organized clinical networks and a relatively rapid path to adoption for minimally invasive technologies, provided they demonstrate clear clinical and economic benefits.

Across Europe, the Middle East & Africa, heterogeneous healthcare financing and regulatory frameworks lead to pronounced intra-regional variation. Countries with centralized health systems emphasize cost-effectiveness and standardized treatment pathways, which can slow adoption until robust comparative-effectiveness data are available, while emerging markets within the region may prioritize durable, lower-cost solutions that simplify logistics. In contrast, the Middle East exhibits pockets of rapid technology uptake driven by targeted healthcare investments and medical tourism initiatives.

Asia-Pacific presents a dual narrative: advanced markets pursue high-end endoscopic platforms and integrated imaging solutions, whereas other jurisdictions focus on expanding access to essential hemostatic devices through decentralized care models and cost-sensitive procurement. Across the region, demographic trends and rising prevalence of anticoagulant use are increasing clinical demand, prompting greater interest in scalable devices and training programs that enable wider adoption in both hospital and outpatient settings.

Competitive narratives emphasize integrated product portfolios, clinical evidence programs, and service models that accelerate adoption and strengthen long-term provider relationships

Competitive positioning among manufacturers is increasingly defined by integrated portfolios, evidence generation capabilities, and service-oriented business models. Leading device companies are investing in modular systems that pair hemostatic agents with dedicated delivery devices, as well as in training and support frameworks that mitigate learning-curve effects and accelerate hospital onboarding. Strategic partnerships between device innovators and clinical research networks are expanding real-world evidence generation, enabling clearer demonstration of procedural efficiency gains and clinical outcomes that resonate with both clinicians and payers.

Smaller, specialized firms are carving niches through material science advances and single-use disposables optimized for specific lesion types or access routes. These focused players often deploy agile commercialization approaches, leveraging targeted clinical publications and center-of-excellence relationships to build credibility. At the same time, larger manufacturers are pursuing horizontal consolidation and licensing agreements to acquire complementary technologies, create bundled offerings, and expand geographic reach, while emphasizing compliance, manufacturing scale, and post-market surveillance as competitive advantages.

Across the ecosystem, companies that align product development with clearly articulated clinical pathways and that support adoption through hands-on training, robust clinical data, and flexible commercial terms are better positioned to capture durable relationships with high-volume centers and integrated delivery networks.

Practical strategic actions for manufacturers and providers to convert clinical innovation into reliable adoption while strengthening supply chain and commercial resilience

Industry leaders should prioritize a set of actionable strategies that address clinical utility, operational resilience, and commercial differentiation. First, invest in clinical evidence generation that links device use to measurable outcomes such as reduced rebleeding rates, shorter procedure times, and lower overall episode-of-care costs; such data support payer discussions and strengthen hospital procurement cases. Second, design devices and accessory systems with supply chain redundancy in mind, reducing reliance on single-source components and enabling rapid substitution pathways in response to policy or logistical disruptions.

Third, develop comprehensive training and proctoring programs that shorten learning curves and embed product usage into standard clinical workflows, ensuring that value propositions translate into routine practice. Fourth, pursue flexible commercial models that include managed service agreements, volume-based pricing, and bundled procurement options tailored to ambulatory, inpatient, and outpatient settings. Fifth, accelerate digital enablement by integrating device telemetry, procedural documentation, and outcomes tracking to create compelling value narratives for providers and payers alike.

Taken together, these actions will help manufacturers and health systems convert clinical innovation into sustainable adoption while protecting margins and ensuring continuity of patient care in a dynamic policy and supply chain environment.

Robust multi-source approach combining clinician interviews, regulatory and technical documentation review, and real-world evidence synthesis to validate trends and insights

This research synthesizes peer-reviewed clinical literature, regulatory filings, product technical specifications, and interviews with procedural clinicians, hospital procurement leaders, and industry executives to assemble a multi-faceted view of the gastrointestinal bleeding device landscape. Primary qualitative insights were gathered through structured interviews with clinicians experienced in endoscopic, radiologic, and surgical management of bleeding, supplemented by anonymized discussions with supply chain and purchasing professionals to understand procurement constraints and contract preferences.

Secondary research included systematic review of clinical trial repositories, device registries, and regulatory documentation to map device indications, safety profiles, and labeling changes. Product literature and real-world evidence reports were analyzed to identify procedural workflows, device compatibility considerations, and training requirements. Cross-referencing of these inputs enabled triangulation of trends and validation of emergent themes. Wherever possible, methodological transparency was maintained by documenting interview protocols, inclusion criteria for literature sources, and the process used to reconcile conflicting evidence.

Limitations of the methodology are acknowledged: evolving device introductions and ongoing post-market studies can shift the evidence base, and access to proprietary hospital procurement data was constrained by confidentiality. To mitigate these limitations, the approach emphasized diversity of sources, iterative expert validation, and explicit notation of assumptions used during synthesis.

Synthesis of critical findings that link clinical innovation, supply chain resilience, and evidence-based adoption to long-term commercial and patient impact

In summary, the gastrointestinal bleeding treatment device sector is at the intersection of clinical necessity and technological opportunity. Advances in hemostatic agents, refined endoscopic accessories, and complementary radiologic options are expanding the therapeutic toolkit available to clinicians, while supply chain pressures and shifting payer expectations are reshaping how products are purchased and used. Strategic differentiation will increasingly depend on the ability to demonstrate clinical effectiveness within specific indication and care-setting contexts, to offer resilient supply and service models, and to provide scalable training that embeds new techniques into routine practice.

Stakeholders who align product development with validated clinical pathways and who invest in the generation of meaningful real-world outcomes will be best positioned to influence procurement decisions and achieve durable market presence. The convergence of digital enablement, targeted evidence generation, and adaptive commercial strategies creates a pathway for translating device innovation into consistent clinical benefit and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Bleeding Treatment Devices Market, by Product Type

  • 8.1. Endoscopic Clips
  • 8.2. Hemostatic Agents
    • 8.2.1. Powder
    • 8.2.2. Sheets
    • 8.2.3. Spray
  • 8.3. Injection Therapy
    • 8.3.1. Alcohol Sclerosant
    • 8.3.2. Epinephrine
    • 8.3.3. Polidocanol
  • 8.4. Thermal Devices
    • 8.4.1. Argon Plasma Coagulation
    • 8.4.2. Bipolar Probes
    • 8.4.3. Heater Probes

9. Gastrointestinal Bleeding Treatment Devices Market, by Technology

  • 9.1. Endoscopic
    • 9.1.1. Flexible Endoscopy
    • 9.1.2. Rigid Endoscopy
  • 9.2. Radiologic
    • 9.2.1. Angiographic Embolization
    • 9.2.2. Mesenteric Stenting
  • 9.3. Surgical
    • 9.3.1. Laparoscopic Surgery
    • 9.3.2. Open Surgery

10. Gastrointestinal Bleeding Treatment Devices Market, by Indication Type

  • 10.1. Lower GI
    • 10.1.1. Colonic Bleeding
    • 10.1.2. Rectal Bleeding
  • 10.2. Upper GI
    • 10.2.1. Duodenal Bleeding
    • 10.2.2. Esophageal Bleeding
    • 10.2.3. Gastric Bleeding

11. Gastrointestinal Bleeding Treatment Devices Market, by Application

  • 11.1. Angiodysplasia
  • 11.2. Dieulafoy Lesion
  • 11.3. Mallory-Weiss Tear
  • 11.4. Peptic Ulcer
  • 11.5. Variceal Bleeding

12. Gastrointestinal Bleeding Treatment Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Gastroenterology Clinics
  • 12.3. Hospitals Inpatient
  • 12.4. Hospitals Outpatient

13. Gastrointestinal Bleeding Treatment Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Bleeding Treatment Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Bleeding Treatment Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastrointestinal Bleeding Treatment Devices Market

17. China Gastrointestinal Bleeding Treatment Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. BTG International Ltd.
  • 18.10. Cantel Medical Corporation
  • 18.11. ConMed Corporation
  • 18.12. Cook Medical LLC
  • 18.13. EndoClot Plus, Inc.
  • 18.14. Erbe Elektromedizin GmbH
  • 18.15. FUJIFILM Holdings Corporation
  • 18.16. HOYA Corporation
  • 18.17. Johnson & Johnson
  • 18.18. KARL STORZ SE & Co. KG
  • 18.19. Medline Industries, Inc.
  • 18.20. Medtronic plc
  • 18.21. Merit Medical Systems, Inc.
  • 18.22. Nipro Corporation
  • 18.23. Olympus Corporation
  • 18.24. Ovesco Endoscopy AG
  • 18.25. Smiths Group plc
  • 18.26. Steris plc
  • 18.27. Teleflex Incorporated
  • 18.28. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 264. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 265. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 266. GCC GA